E-LIB Suche - Ergebnisse für: Bethge, W

1

Axicabtagene ciloleucel (Axicel) for relapsed/refractory pr..:

Schubert, M. ; Ayuk, F. A. ; Bethge, W....
Hematological Oncology. 41 (2023) S2 - p. 411-412 , 2023

Link: https://doi.org/10.1002/..

2

Prognostic factors for cellular therapies ‐ CART and alloge..:

Glass, B. ; Sureda, A. ; Boumendil, A....
Hematological Oncology. 41 (2023) S2 - p. 449-451 , 2023

Link: https://doi.org/10.1002/..

3

SEVERE HEMATOLOGICAL TOXICITY FOLLOWING CD19 CAR‐T FOR RELA..:

Rejeski, K. ; Perez, A. ; Iacoboni, G....
Hematological Oncology. 41 (2023) S2 - p. 204-204 , 2023

Link: https://doi.org/10.1002/..

4

P1458: PATTERNS OF LONG-TERM HEMATOPOIETIC RECOVERY IMPACT ..:

Rejeski, K. ; Albanyan, O. ; Iacoboni, G....
HemaSphere. 6 (2022) - p. 1340-1341 , 2022

Link: https://doi.org/10.1097/..

5

P957: CARFILZOMIB, LENALIDOMIDE, DEXAMETHASONE FOLLOWED BY ..:

Tilmont, R. ; Yakoub-Agha, I. ; Eikema, D.-J....
HemaSphere. 6 (2022) - p. 847-848 , 2022

Link: https://doi.org/10.1097/..

6

P1448: LONG-TERM SURVIVORS AFTER FAILURE OF CAR-T CELL THER..:

Derigs, P. ; Bethge, W. ; Holtick, U....
HemaSphere. 6 (2022) - p. 1331-1332 , 2022

Link: https://doi.org/10.1097/..

7

CAR‐HEMATOTOX: A DISCRIMINATIVE MODEL FOR CAR T‐CELL RELATE..:

Rejeski, K. ; Perez, A. ; Sesques, P....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

8

OUTCOME DETERMINANTS OF COMMERCIAL CAR‐T CELL THERAPY FOR L..:

Dreger, P. ; Martus, P. ; Holtick, U....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

9

Retrospective single center analysis of outcome, risk facto..:

Axt, L. ; Naumann, A. ; Toennies, J....
Bone Marrow Transplantation. 54 (2019) 11 - p. 1805-1814 , 2019

Link: https://doi.org/10.1038/..

10

Allogeneic hematopoietic cell transplantation in patients ⩾..:

Haen, S P ; Pham, M ; Faul, C...
Blood Cancer Journal. 6 (2016) 7 - p. e443-e443 , 2016

Link: https://doi.org/10.1038/..

11

Allogene hämatopoetische Stammzelltransplantation: Eine Opt..:

Wirths, S. ; Bethge, W. ; Henes, J. C.
Zeitschrift für Rheumatologie. 75 (2016) 8 - p. 780-785 , 2016

Link: https://doi.org/10.1007/..

12

Allogeneic hematopoietic cell transplantation as curative t..:

Heinzelmann, F ; Bethge, W ; Beelen, D W...
Bone Marrow Transplantation. 51 (2016) 5 - p. 654-662 , 2016

Link: https://doi.org/10.1038/..

13

Allogeneic hematopoietic cell transplantation in patients w..:

Schneidawind, D. ; Nann, D. ; Vogel, W....
Transplant Infectious Disease. 14 (2012) 6 - p. , 2012

Link: https://doi.org/10.1111/..

14

A Randomized Phase III Trial Investigating 2 Gy TBI Vs. Flu..:

Kornblit, B. ; Storer, B. ; Storb, R.F....
Biology of Blood and Marrow Transplantation. 18 (2012) 2 - p. S214 , 2012

Link: https://doi.org/10.1016/..

15

Thrombozytopenie: Ist die therapeutische Thrombozytengabe e..:

Bethge, W.
DMW - Deutsche Medizinische Wochenschrift. 137 (2012) 50 - p. 2630-2630 , 2012

Link: https://doi.org/10.1055/..